Accendra Health IncACH
ASignal's systematic analysis rates ACH as Bearish.
Reflects the latest available analysis · analyzed Aug 20, 2026
The case on ACH
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Oversold RSI at 20.64 suggesting potential reversal
- Free cash flow positive at $420.23M
- Gross margin strong at 44.83%
- Low forward P/E of 8.82x
- PEG ratio of 0.70x indicates potential undervaluation relative to growth
- Negative MACD and declining momentum
- Price below all key moving averages (SMA20, SMA50, EMA20)
- Negative net and operating margins
- High debt of $1.82B with low cash reserves
- Poor liquidity with current ratio of 0.41x and quick ratio of 0.19x
- Declining revenue growth (YoY: -10.10%)
See the full verdict on ACH
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ACH
Most investors never get a second opinion, let alone several. ASignal runs ACH past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.